Testing an intensive stroke therapy program delivered at home
Compares home-based and clinic-based intensive therapy in adults with chronic stroke.
Plain-language title generated from the registry record
Registry title: Implementation of a HABIT-ILE Intervention at Home for Chronic Stroke
Key facts
- Where
- Brussels, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a stroke more than 6 months ago and can still move the affected arm a little.
- Age
- 18 Years to 100 Years
- Sex
- All sexes can join.
- Disease stage
- Chronic stroke, older than 6 months.
- Earlier treatment
- No botulinum toxin injection, no intensive therapy and no surgery that could affect the tests or therapy in the last 6 months before the first assessment or during the therapy.
Main reasons for not taking part
- Seizures that are not controlled
- Botulinum toxin injection in the last 6 months or during the therapy
- Intensive therapy in the last 6 months or during the therapy
- Surgery that could affect the assessments or therapy in the last 6 months or during the therapy
- Severe visual or cognitive impairments that interfere with treatment or assessments
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT05727111, who can take part
Where in Belgium
- MSL-IN lab, IoNS, UCLouvainBrussels, BelgiumContact: Yannick Bleyenheuft, Phd, Prof.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Université Catholique de Louvain
- Trial code
- NCT05727111
- Record updated
- 9 May 2023
- Original description
This study will use a randomized controlled trial design to assess the possible difference between two intensive treatment programs: a classic "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) therapy and a HABIT-ILE therapy implemented at the patient's home. Moreover, this study also aims to assess whether the patient's abilities are better with follow-up than without follow-up after two weeks of HABIT-ILE therapy. The possible difference between the therapies will be studied in terms of functional capacities, activities and social participation.Read full original descriptionShow less
Implementation of a HABIT-ILE Intervention at Home for Individuals With Chronic Stroke: a Non-inferiority Randomized Controlled Trial
This study will use a randomized controlled trial design to assess the possible difference between two intensive treatment programs: a classic "Hand and Arm Bimanual Intensive Therapy Including Lower Extremities" (HABIT-ILE) therapy and a HABIT-ILE therapy implemented at the patient's home. Moreover, this study also aims to assess whether the patient's abilities are better with follow-up than without follow-up after two weeks of HABIT-ILE therapy. The possible difference between the therapies will be studied in terms of functional capacities, activities and social participation.
Inclusion: Adults with a chronic stroke (older than 6 months); Ability to interact and understand simple instructions in order to complete assessments and therapy; Ability to perform a partial shoulder flexion or abduction, a partial elbow extension, and hold an object in the paretic hand; Availability of a caregiver for 6h30 per day during two weeks of therapy.
Exclusion: Botulinum toxin injection in the last 6 months before the first assessment or during the therapy; Intensive therapy in the last 6 months before the first assessment or during the therapy; Surgery that could affect the assessments or therapy in the last 6 months before the first assessment or during the therapy; Non controlled seizure; Severe visual or cognitive impairments interfering with treatment and or assessments.